CooperVision Introduces MyDay Daily Disposable Multifocal Contact Lenses in US
At the 2021 American Academy of Optometry Meeting, CooperVision introduced MyDay daily disposable multifocal contact lenses, expanding its premium silicone hydrogel 1 day family in the United States.
The new lenses are the first to feature the CooperVisionBinocular Progressive System, an innovative 3 ADD approach that caters to all levels of presbyopia with a simple fitting process,1 optimal visual acuity at all distances and comfortable wear for exceptional performance.2 Eye care professionals (ECPs) can successfully fit 98% of patients with two pairs of MyDay multifocal lenses or fewer when following the fitting guide.1
“As people age into presbyopia, they often turn to reading glasses over their contact lenses or drop out entirely,"3 said Michele Andrews, OD, Vice President of Professional and Government Affairs, Americas, CooperVision. “These patients need a contact lens that checks all the boxes: excellent vision, comfort, and ocular health.4 MyDay multifocal will help ECPs further build their practices and energize the category.”
At launch, MyDay multifocal will be available in the broadest range of any daily disposable multifocal contact lens on the market,5 with an 8.4 mm base curve, 14.2 mm diameter and an extensive power range from +8.00D to -10.00D (in 0.25D steps) and -10.50D to -12.00D (in 0.50D steps). The three ADD powers include low (+0.75D to +1.25D spectacle Rx ADD), medium (+1.50D to +1.75D spectacle Rx ADD) and high (+2.00D to +2.50D spectacle Rx ADD). Oxygen transmissibility (Dk/t) at -3.00D is 100 x 10-9 and the lenses offer 85% UVA and 96% UVB blocking.*
Fitting, Vision and Comfort Innovations
The CooperVision Binocular Progressive System debuts with MyDay multifocal. The 3 ADD method uses different lens designs to optimize vision for all levels of presbyopia.6 These allow the eyes to work in tandem, which gives a simple initial fit and an easy progression as the near requirement increases. Wearers embrace the lens from the start, with 100% overall fit acceptance on dispensing.1 That performance helps wearers get back on the go and spend more time on the things that matter most to them—and may give ECPs more time to fit more patients.
“ECPs recognize the opportunities that MyDay multifocal present for their patients and their practices. In a recent assessment, 100% of ECPs agreed that MyDay multifocal contact lenses are a better option for their patients than fitting single vision MyDay lenses with reading glasses.± In addition, 98% of ECPs agreed that MyDay multifocal contact lenses are an excellent option for new patients with presbyopia who are interested in wearing contact lenses,"2 said CooperVision’s Dr. Andrews.
Fitting the new lens is made easier with OptiExpert—a suite of tools to aid in fitting decisions, reduce chair time8 and increase patient success. This includes a new capability of refining first fit for vision optimization. OptiExpert is available to download on the Apple App Store and Google Play. The desktop version can be used at https://coopervision.com/practitioner/tools-and-calculators/optiexpert/optiexpert-web.
For additional information, please visit https://coopervision.com/practitioner/our-products/myday-family/myday-multifocal.
References:
1. CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® daily disposable multifocal; n=104 habitual multifocal contact lens wearers; CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® daily disposable multifocal; n=58 habitual multifocal contact lens wearers.
2. CVI data on file 2021. Observational in-practice assessment with MyDay® multifocal in US with 40 ECPs and 372 wearers.
3. Akerman D. 40 is the New 20/20 — Presbyopia Equals Opportunity. CL Spectrum, March 2010.
4. CVI data on file 2020. Kubic Online Survey with spherical soft contact lens wearers with presbyopia/symptoms. N= 1005 (555 1 Day, 450 FRP wearers). US, UK, JP; weighted equally.
5. CooperVision data on file 2021. Based on prescription option combinations (sph and add) available across all daily disposable multifocal soft lenses from CVI, JJV, B+L and Alcon in USA May 2021.
6. CVI data on file 2020. Prospective, double-masked, bilateral, 1-week dispensing study with MyDay daily disposable multifocal; n=104 habitual MFCL wearers.
7. Initial dispensing visit. CVI data on file 2021. Observational in-practice assessment with MyDay® multifocal in US with 48 ECPs and 372 wearers.
8. Based on retrospective analysis of 26 patients (52 eyes) with subjective refractions ranging between +5.00D to -6.00D and ≤ -1.00 D cylinder.